Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Multiple Myeloma 55Neoplasms, Plasma Cell 22Central Nervous System Neoplasms 10Prostatic Neoplasms 9Glioblastoma 9Recurrence 8Melanoma 8Brain Neoplasms 8Neoplasms 7Gliosarcoma 7Carcinoma, Non-Small-Cell Lung 7Sarcoma 6Leukemia 6Carcinoma, Hepatocellular 6Waldenstrom Macroglobulinemia 5Myeloproliferative Disorders 5Lung Neoplasms 5Leukemia, Lymphocytic, Chronic, B-Cell 5Glioma 5Colorectal Neoplasms 5Myelodysplastic-Myeloproliferative Diseases 4Myelodysplastic Syndromes 4Lymphoma 4Liver Neoplasms 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Kidney Neoplasms 4Carcinoma, Renal Cell 4Lymphoma, Mantle-Cell 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Myelomonocytic, Chronic 3

Interventions

Ifosfamide 15Methotrexate 12Doxorubicin 12Filgrastim 10Cisplatin 10Cyclophosphamide 9Etoposide 8Gemcitabine 7cabozantinib 6apatinib 6Magnetic Resonance Spectroscopy 6Leucovorin 6X-Rays 5Specimen Handling 5Sirolimus 5Phantoms, Imaging 5Nivolumab 5Neoadjuvant Therapy 5camrelizumab 4Vincristine 4Topotecan 4Radiotherapy 4Nuclear Medicine Department, Hospital 4Drug Therapy 4Docetaxel 4Biopsy 4regorafenib 3palbociclib 3olaparib 3mifamurtide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Osteosarcoma × Thalidomide × Clear all
NCT00026416 2014-01-06

Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma

National Cancer Institute (NCI)

Phase 2 Unknown
Sarcoma

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡